In an effort to address this knowledge gap, we aimed to study the associations of the 21-gene RS with metabolic risk factors and circulating biomarkers of insulin and the IGF axis, and characterize the prognosis prediction interaction between the 21-gene RS and metabolic profiles in Chinese women with hormone receptor (HR)-positive, HER2-negative early-stage breast cancer. The gene discussed is INS; the disease is breast cancer.